Asian Annals
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Norihide Fukushima
Yuji Miyamoto
Shigeaki Ohtake
Yoshiki Sawa
Toshiki Takahashi
Motonobu Nishimura
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fukushima, N.
Right arrow Articles by Nishimura, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fukushima, N.
Right arrow Articles by Nishimura, M.
Related Collections
Right arrow Transplantation - heart
Asian Cardiovasc Thorac Ann 2004;12:154-158
© 2004 Asia Publishing EXchange Ltd


ORIGINAL CONTRIBUTION

Early Result of Heart Transplantation in Japan: Osaka University Experience

Norihide Fukushima, MD, Yuji Miyamoto, MD, Shigeaki Ohtake, MD, Yoshiki Sawa, MD, Toshiki Takahashi, MD, Motonobu Nishimura, MD

Division of Cardiovascular Surgery, Department of Surgery, Osaka University Graduate School of Medicine, Osaka, Japan

For reprint information contact: Norihide Fukushima, MD Tel: 81 6 6879 3154 Fax: 81 6 6879 3163 Email: nori{at}surg1.med.osaka-u.ac.jp 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan.

Since the new organ transplantation law was established in 1997, 17 heart transplantations have been performed in Japan, 7 of which were carried out at Osaka University Hospital. Recipient diagnosis was dilated cardiomyopathy in 2, dilated phase of hypertrophic cardiomyopathy in 4, and post-myocarditis cardiomyopathy in 1. Ages ranged from 8 to 49 years with a mean of 35.3 years. Five patients were bridged with a left ventricular assist device. The waiting period was 182–977 days (mean, 643 days). There was no early or late death during follow-up of 1–4.8 years. Under a standard triple-drug regimen using mycophenolate, there were 3 rejection episodes greater than grade 3 in 2 patients, and humoral rejection requiring plasmapheresis in one. A young boy whose donor was a hemodynamically compromised adult developed neurological sequelae after resuscitation following ventricular tachycardia. All patients were discharged and went back to work or their regular daily life. Although the donor shortage is still severe in Japan, the resumption of heart transplantation has been satisfactory, and left ventricular assist devices have played a crucial role.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2004 by the Asia Publishing EXchange Ltd.